Document:

emma-ex438_358.htm

Exhibit 4.38

THIS CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). NO SALE OR DISPOSITION MAY BE AFFECTED EXCEPT IN COMPLIANCE WITH RULE 144 UNDER SAID ACT OR AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN APPLICABLE EXEMPTION THEREFROM.

 

EMMAUS LIFE SCIENCES, INC.

Convertible Promissory Note

Principal Amount:                 Loan Date:                  

Currency:U.S. DollarsTerm:                   

Interest Rate:10% Loan Due Date:          

Interest Payment Period:  Interest is accrued and paid upon Loan Due Date

Lender:                                                                                                                                                                                                                  

FOR VALUE RECEIVED, Emmaus Life Sciences, Inc., a Delaware corporation, located at 21250 Hawthorne Blvd., Suite 800, Torrance, CA  90503 (“Borrower”) hereby promises to pay to the order of Lender the sum of the Principal Amount in the stated Currency, together with any accrued interest at the stated Interest Rate, under the following terms and conditions of this Convertible Promissory Note (“Note”).

 

1. Terms of Repayment (Balloon Payment): The entire unpaid Principal Amount and any accrued interest shall become immediately due and payable upon the stated Loan Due Date. Simple interest at the stated Interest Rate will accrue on the outstanding Principal Amount commencing on the stated Loan Date. 

 

2. Prepayment: This Note may be prepaid in whole or in part at any time without premium or penalty upon ten days advance written notice by Borrower to Lender. All prepayments shall first be applied to interest, and then to principal payments.

 

3. Place of Payment: All payments due under this Note shall be sent to the Lender’s address, as noted in Attachment 1 hereto, or at such other place as the Lender or subsequently assigned holder (“Holder”) of this Note may designate in writing in the future.

 

4. Conversion:

 

(a)Mandatory Conversion:   Upon the listing of shares of common stock of the Borrower (“Common Stock”) on the OTC market or trading on a national securities exchange (the “Qualification”), (i) the entire outstanding Principal Amount of this Note shall automatically be converted into the number of shares of Common Stock determined by dividing (x) the outstanding Principal Amount of this Note by a fixed share price of $4.50 (subject to appropriate adjustment in the event of any stock splits, stock dividends, recapitalizations and similar transactions with respect 

 

 

to the capital stock of Borrower). Within thirty days of such closing, all accrued and unpaid interest on the Note, if any, will be paid to the Holder in cash.  

 

The Borrower shall notify the holder of this Note at least seven (7) calendar days following the Qualification. Thereafter, the holder of this Note shall deliver this Note to the Borrower and, as soon as reasonably practicable thereafter, the Borrower shall issue and deliver to the holder of this Note a certificate or certificates for the number of full shares of Common Stock issuable upon the conversion of this Note, and provision shall be made for any fraction of a share as provided in Section 4(b) below.  At the time of the Qualification, and provided that the Borrower has complied fully with all of its obligations under this Section 4(a), the holder of this Note shall not have any further rights under this Note (including the right to receive payment of principal or interest hereunder) other than those rights set forth in this Section 4.

 

(b)Fractional Shares:  No fractional shares or scrip shall be issued upon conversion of this Note.  The number of full shares of Common Stock issuable upon conversion of this Note shall be computed on the basis of the aggregate value of outstanding principal of and, as applicable in accordance with the terms of this Section 4, accrued interest on this Note so surrendered.  The value of any fractional shares of Common Stock shall be paid in cash.

 

(c)Conversion at the Election of the Holder:  If the mandatory conversion is not executed, by or after the first anniversary of the Loan Date, Lender may by giving written Notice of Conversion to the Borrower in the form attached hereto as Exhibit A, elect to convert some or all of the unpaid Principal Amount, including up to all the interest accrued and unpaid thereon, into a number of shares of Common Stock determined by dividing (x) the outstanding Principal Amount of this Note by (y) the Conversion Price Per Share. As used in this Section 4(c), “Conversion Price Per Share” means $4.50 per share of Common Stock (subject to appropriate adjustment in the event of any stock splits, stock dividends, recapitalizations and similar transactions with respect to the capital stock of Borrower). Within two weeks following receipt of such Notice of Conversion, Borrower shall deliver to Lender one or more original stock certificates representing the full number of shares of Common Stock issuable upon such conversion, and provision shall be made for any fraction of a share as provided in Section 4(b) above. Upon such conversion, and provided that the Borrower has complied fully with all of its obligations under this Section 4(c), the holder of this Note shall not have any further rights under this Note (including the right to receive payment of principal or interest hereunder) other than those rights set forth in this Section 4.

 

5. Default: In the event of default, the Borrower agrees to pay all costs and expenses incurred by the Lender, including all reasonable attorney fees as permitted by law for the collection of this Note upon default.

 

6. Acceleration of Debt: If the Borrower (i) fails to make any payment due under the terms

of this Note or seeks relief under the U.S. Bankruptcy Code, (ii) fails to deliver shares to the Lender by the deadline set forth in Section 4 hereof, (iii) suffers an involuntary petition in bankruptcy or receivership that is not vacated within thirty (30) days, (iv) consents to the appointment of a receiver, trustee, assignee, liquidator or similar official or such appointment is not discharged or stayed within 30 days, (v) makes a general assignment for the benefit of its creditors or (vi) admits in writing that it is generally unable to pay its debts as they become due, the entire balance of this Note and any interest accrued thereon shall be immediately due and payable to the holder of this Note.

 

 

 

7. Modification: No modification or waiver of any of the terms of this Note shall be allowed unless by written agreement signed by the Borrower and the Lender. No waiver of any breach or default hereunder shall be deemed a waiver of any subsequent breach or default of the same or similar nature.

 

8. Complete Note: This Note is the complete and exclusive statement of agreement of the Borrower and Lender with respect to matters in this Note. This Note replaces and supersedes all prior written or oral agreements or statements by and among the Borrower and Lender with respect to the matters covered by it. No representation, statement, condition or warranty not contained in this Note is binding on either the Borrower or Lender. Each Holder of this Note, by its acceptance hereof, agrees to be bound by, and shall be entitled to the benefits of, the terms set forth herein.

 

9. Transfer of the Note: 

 

(a)  Subject to Section 9(b) hereof, this Note may be transferred, in whole or in part, at any time or from time to time, by the Lender. The Borrower hereby agrees to remain bound by the terms of this Note subsequent to any such transfer, and agrees that the terms of this Note may be fully enforced by any subsequent holder of this Note. If this Note is to be transferred, the Lender shall surrender this Note to the Borrower, together with such additional documentation as the Lender may reasonably request, whereupon the Borrower will forthwith issue and deliver upon the order of the Lender a new Note registered as the Lender may request, representing the outstanding Principal Amount being transferred by the Lender and, if less then the entire outstanding Principal Amount is being transferred, a new Note to the Lender representing the outstanding Principal Amount not being transferred. The person in whose name this Note or any new Note issued in replacement hereof shall be registered shall be deemed and treated as the owner and holder thereof, and the Borrower shall not be affected by any notice or knowledge to the contrary except as provided in this Section 9(a). This Note may not be transferred by the Borrower, by operation of law or otherwise, without the prior written consent of the Lender. 

 

(b) Lender acknowledges and agrees that this Note has been acquired for investment and has not been registered under the securities laws of the United States of America or any state thereof.  Accordingly, notwithstanding Section 9(a), neither this Note nor any interest thereon may be offered for sale, sold or transferred in the absence of registration under applicable federal and state securities laws or an opinion of counsel of the Holder reasonably satisfactory to the Borrower that such registration is not required.  

 

10. Lost, Stolen or Mutilated Note:  Upon receipt by the Borrower of evidence reasonably satisfactory to the Borrower of the loss, theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Lender to the Borrower in customary form and, in the case of mutilation, upon surrender and cancellation of this Note, the Borrower shall execute and deliver to the Lender a new Note representing the outstanding Principal Amount and accrued and unpaid interest thereon.

 

11. Remedies:  The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Lender’s right to pursue actual and consequential damages for any failure by the Borrower to comply with the terms of this Note.  

 

 

 

12. Severability of Provisions: If any portion of this Note is deemed unenforceable, all other provisions of this Note shall remain in full force and effect.

 

13. Choice of Law: All terms and conditions of this Note shall be interpreted under the laws

of California, U.S.A., without regard to conflict of law principles.

 

 

 

Signed Under Penalty of Perjury, this     day of     ,  

 

Emmaus Life Sciences, Inc.

 

 

 

_______________________________________

By: 

 

 

Acknowledged and accepted by Lender

 

 

 

_______________________________________

By: 

 

 

 

ATTACHMENT 1

 

Lender’s Name: 

Lender’s Address: 

 

 

 

 

 

EXHIBIT A

NOTICE OF CONVERSION

(To be executed by the Lender in order to convert the Note)

		
	
TO:  Emmaus Life Sciences, Inc.
	
 

 

	
The undersigned hereby irrevocably elects to convert $
	
 of the principal amount of the Note issued to the Lender by Emmaus Life Sciences, Inc. (the “Company”) into shares of Common Stock of the Company according to the conditions stated therein, as of the Conversion Date written below.

		
	
Conversion Date:
	
 

	
Applicable Conversion Price:
	
 

	
Signature:
	
 

	
Name:
	
 

	
Address:
	
 

	
Amount to be converted:
	
$  

	
Amount of Note unconverted:
	
$  

	
Number of shares of Common Stock to be issued:
	
 

	
Please issue the shares of  Common Stock in the following name and to the following address:
	
 

	
Address:
	
 

	
Address:
	
 

	
Phone Number:
	
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[INFORMATION FOR PURPOSES OF FILING WITH THE SECURITIES AND EXCHANGE COMMISSION]

 

SCHEDULE A

 

NOTEHOLDERS

 

	
Lender
	
 
	
Annual
Interest

Rate
	
 
	
Date of
loan
	
 
	
Term of
Loan
	
 
	
Loan Due
Date
	
 
	
Principal Loan
Amount
	
 
	
Interest Payment
Period
	
 
	
Conversion
Price
	
 

	
Aiko Yamagata
	
 
	
10.0%
	
 
	
11/11/2018
	
 
	
1 year
	
 
	
11/11/2019
	
 
	
$
	
55,006
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Hiroomi Nakamura
	
 
	
10.0%
	
 
	
11/13/2018
	
 
	
 

1 year
	
 
	
11/13/2019
	
 
	
$
	
49,530
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Kazushige Nishimura
	
 
	
10.0%
	
 
	
11/13/2018
	
 
	
1 year
	
 
	
11/13/2019
	
 
	
$
	
24,545
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Toshiaki & 

Akemi Kato
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
 

 

1 year
	
 
	
11/15/2019
	
 
	
$
	
306,465
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Junko Yonemochi
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
1 year
	
 
	
11/29/2019
	
 
	
$
	
154,700
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Nobuaki Yonemochi
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
 

1 year
	
 
	
11/29/2019
	
 
	
$
	
121,550
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Masayuki Chibana
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
1 year
	
 
	
11/29/2019
	
 
	
$
	
49,112
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Kaoru Maeda
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
 

1 year
	
 
	
11/29/2019
	
 
	
$
	
48,151
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Fumitoshi Ishikawa
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
1 year
	
 
	
11/29/2019
	
 
	
$
	
24,642
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Masako Hasegawa
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
 

1 year
	
 
	
11/29/2019
	
 
	
$
	
24,564
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Masuyo Eida
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
1 year
	
 
	
11/29/2019
	
 
	
$
	
23,840
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Masao Fujita
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
 

1 year
	
 
	
11/29/2019
	
 
	
$
	
16,575
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Keiko Kawazoe
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
1 year
	
 
	
11/29/2019
	
 
	
$
	
12,321
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Kumiko Shiragami
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
 

1 year
	
 
	
11/29/2019
	
 
	
$
	
12,321
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Tetsuo Kinjo
	
 
	
10.0%
	
 
	
11/29/2018
	
 
	
1 year
	
 
	
11/29/2019
	
 
	
$
	
12,321
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Yasuyuki Suzuki
	
 
	
10.0%
	
 
	
11/30/2018
	
 
	
 

1 year
	
 
	
11/30/2019
	
 
	
$
	
56,590
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Mihoko Ota
	
 
	
10.0%
	
 
	
11/30/2018
	
 
	
1 year
	
 
	
11/30/2019
	
 
	
$
	
23,846
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
M's Support, Ltd.
	
 
	
10.0%
	
 
	
11/30/2018
	
 
	
 

1 year
	
 
	
11/30/2019
	
 
	
$
	
12,324
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Masaru & 

Setsuko Fujiwara
	
 
	
10.0%
	
 
	
12/1/2018
	
 
	
1 year
	
 
	
12/1/2019
	
 
	
$
	
12,327
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Keiko Furukawa
	
 
	
10.0%
	
 
	
12/11/2018
	
 
	
 

1 year
	
 
	
12/11/2019
	
 
	
$
	
12,357
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Yoshiko Takemoto
	
 
	
10.0%
	
 
	
12/27/2018
	
 
	
1 year
	
 
	
12/27/2019
	
 
	
$
	
123,622
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50emma-ex439_362.htm

Exhibit 4.39

THIS CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS.  ACCORDINGLY, NEITHER THIS CONVERTIBLE PROMISSORY NOTE NOR THE SECURITIES INTO WHICH IT MAY BE CONVERTED MAY BE OFFERED FOR SALE, SOLD OR TRANSFERRED IN THE ABSENCE OF REGISTRATION UNDER APPLICABLE FEDERAL AND STATE SECURITIES LAWS OR AN OPINION OF COUNSEL OF THE HOLDER REASONABLY SATISFACTORY TO THE BORROWER THAT SUCH REGISTRATION IS NOT REQUIRED.

 

EMMAUS LIFE SCIENCES, INC.

Convertible Promissory Note

Original Loan Issued Date: _______________

Principal Amount: Loan Date: 

Currency:U.S. DollarsTerm:            

Interest Rate:10% Per AnnumLoan Due Date: 

Interest Payment Period:  Interest is payable upon Loan Due Date

Lender:

FOR VALUE RECEIVED, Emmaus Life Sciences, Inc., a Delaware corporation, located at 21250 Hawthorne Blvd., Suite 800, Torrance, CA  90503 (“Borrower”), hereby promises to pay to the order of Lender or other holder of this Note (each, a “Holder”) the Principal Amount in the stated Currency, together with accrued interest at the stated Interest Rate, under the following terms of this Convertible Promissory Note (“Note”).

1.Terms of Repayment (Balloon Payment): Unless previously converted as provided herein, the entire unpaid Principal Amount and all accrued and unpaid interest shall become immediately due and payable upon the stated Loan Due Date. Simple interest at the stated Interest Rate will accrue on the outstanding Principal Amount commencing on the stated Loan Date.

2.Prepayment: This Note may be prepaid in whole or in part at any time without premium or penalty.  All prepayments shall first be applied to accrued and unpaid interest and then to the outstanding Principal Amount.

3.Place of Payment: All payments due under this Note shall be sent to the Lender’s address, as noted in Attachment 1 hereto, or at such other place as the Lender or other Holder may designate in writing in the future.

4.Conversion:

 

-  .

 

(a)Mandatory Conversion:  Upon the qualification of Borrower common stock (“Common Stock”) for quotation on the OTC Market or trading on a national securities exchange (the “Qualification”), (i) the entire outstanding Principal Amount plus all accrued and unpaid interest of this Note shall automatically be converted into the number of shares of Common Stock determined by dividing (x) the outstanding Principal Amount of this Note by $4.50, subject to appropriate adjustment in the event of any stock split, stock dividend, recapitalization or similar change with respect to the Common Stock (as so adjusted, the “Conversion Price”).  Within thirty (30) days of the Qualification, but not later than the Loan Due Date, any and all accrued and unpaid interest on the Note will be paid to the Holder in cash.  

The Borrower shall notify the Holder not more than seven (7) days following the Qualification.  Thereafter, the Holder shall deliver this Note to the Borrower, and the Borrower shall issue and deliver to the Holder of this Note one or more stock certificates for the number of full shares of Common Stock issuable upon the conversion of this Note.  At the time of the Qualification, the Holder shall not have any rights under this Note (including the right to receive payment of the Principal Amount or accrued interest hereunder) other than those rights set forth in this Section 4.

(b)Conversion at the Election of the Holder:  At any time, or from time to time, on or prior to the Loan Due Date, unless this Note shall have previously been converted as provided in Section 4(a), the Holder may, by giving written Notice of Conversion to the Borrower in the form attached hereto as Exhibit A, elect to convert some or all of the outstanding Principal Amount of and accrued and unpaid interest on this Note into shares of Common Stock at the Conversion Price.  Within two weeks following receipt of such Notice of Conversion, Borrower shall deliver to Lender one or more stock certificates representing the full number of shares of Common Stock issuable upon such conversion.  Upon such conversion, the Principal Amount of any accrued and unpaid interest, as applicable, on this Note shall be reduced accordingly.  Upon partial conversion of this Note, a new convertible promissory note of like tenor shall, upon the Holder’s surrender and delivery to Borrower of this Note, be issued by Borrower to the Holder for the Principal Amount of this Note which shall not have been so converted.

(c)Fractional Shares:  No fractional shares or scrip shall be issued upon conversion of this Note.  The value, as determined in good faith by the Borrower, of any fractional share of Common Stock otherwise issuable upon conversion of this Note shall be paid to the Holder by the Borrower in cash concurrently with the Borrower’s delivery of the stock certificates as provided in Section 4(a).

(d)Redemption Right.  The Lender acknowledges and agrees that the shares of Common Stock issued upon conversion of this Note shall be redeemable by the Borrower in its discretion as provided in Exhibit B attached hereto.

5.Merger:  If the Borrower at any time shall consolidate with, merge into, or sell or convey all or substantially all its assets to, any other entity, this Note, as to the unpaid Principal Amount hereof and accrued interest hereon, shall thereafter be deemed to evidence the right to acquire upon conversion such number and kind of shares or other securities and property as would have been issuable or distributable on account of such consolidation, merger, sale or conveyance, with respect to the Common Stock issuable upon conversion of this Note immediately prior to such 

2

-  .

 

consolidation, merger, sale or conveyance.  The foregoing provision shall similarly apply to successive transactions of a similar nature by any such successor or purchaser.  Without limiting the generality of the foregoing, the anti-dilution provisions of this Note shall apply to such securities of such successor or purchaser after any such consolidation, merger, sale or conveyance.

6.Default: In the event of default under this Note, the Borrower agrees to pay all costs and expenses incurred by the Holder, including all reasonable attorney fees as permitted by law, for the enforcement or collection of this Note.

7.Acceleration of Debt: If the Borrower (i) fails to make any payment due under the terms of this Note or seeks relief under the U.S. Bankruptcy Code, (ii) fails to deliver shares to the Holder as provided in Section 4 hereof, (iii) suffers an involuntary petition in bankruptcy or receivership that is not vacated within thirty (30) days, (iv) consents to the appointment of a receiver, trustee, assignee, liquidator or similar official or such appointment is not discharged or stayed within 30 days, (v) makes a general assignment for the benefit of its creditors or (vi) admits in writing that it is generally unable to pay its debts as they become due, the entire outstanding Principal Amount of any and all accrued and unpaid interest thereon shall be immediately due and payable to the Holder.

8.Modification: No modification or waiver of any of the terms of this Note shall be allowed unless by written agreement signed by the Borrower and the Lender. No waiver of any breach or default hereunder shall be deemed a waiver of any subsequent breach or default of the same or similar nature.

9.Complete Note: This Note, including the Exhibits hereto, is the complete and exclusive statement of agreement of the Borrower and Lender with respect to matters in this Note. This Note replaces and supersedes all prior written or oral agreements or statements by and among the Borrower and Lender with respect to the matters covered by it. No representation, statement, condition or warranty not contained in this Note is binding on either the Borrower or Lender. Each Holder of this Note, by its acceptance hereof, agrees to be bound by, and shall be entitled to the benefits of, the terms set forth herein.

10.Transfer of the Note: 

(a)Subject to Section 9(b) hereof, this Note may be transferred, in whole or in part, at any time or from time to time, by the Lender or other Holder.  If this Note is to be transferred, the Holder shall surrender this Note to the Borrower, together with such additional documentation as the Borrower may reasonably request, whereupon the Borrower will forthwith issue and deliver upon the order of the Holder’s transferee a new convertible promissory note of like tenor representing the outstanding Principal Amount being transferred and, if less than the entire outstanding Principal Amount is being transferred, a new convertible promissory note of like tenor to the Holder in the Principal Amount of this Note not being transferred. The person in whose name this Note or any new Note issued in replacement hereof shall be registered shall be deemed and treated as the owner and Holder thereof, and the Borrower shall not be affected by any notice or knowledge to the contrary. 

3

-  .

 

(b)Lender acknowledges and agrees that this Note has been acquired, and any shares issuable upon conversion of this Note will be acquired, for investment for the account of Lender only, and not with a view to resale or distribution and has not been, and will not be, registered under the securities laws of the United States of America or any state thereof.  Accordingly, neither this Convertible Promissory Note nor the securities into which it may be converted may be offered for sale, sold or transferred in the absence of registration under applicable federal and state securities laws or an opinion of counsel of the Holder reasonably satisfactory to the Borrower that such registration is not required.  

11.Lost, Stolen or Mutilated Note:  Upon receipt by the Borrower of evidence reasonably satisfactory to the Borrower of the loss, theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of a written indemnification undertaking by the Holder to the Borrower in customary form and, in the case of mutilation, upon surrender and cancellation of this Note, the Borrower shall execute and deliver to the Holder a new convertible promissory note of like tenor representing the outstanding Principal Amount and accrued and unpaid interest thereon.

12.Remedies:  The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note at law or in equity (including a decree of specific performance and/or other injunctive relief). 

13.Severability of Provisions: If any portion of this Note is deemed unenforceable, all other provisions of this Note shall remain in full force and effect.

14.Choice of Law: All terms and conditions of this Note shall be interpreted under the laws of California, U.S.A., without regard to conflict-of-law principles.

Signed Under Penalty of Perjury, this _______ day of _____, ______

 

Emmaus Life Sciences, Inc.

 

 

By:

 

Name:

 

Title:

 

 

Acknowledged and accepted by Lender

 

 

 

_______________________________________

By: 

 

 

4

-  .

 

 

ATTACHMENT 1

 

Lender’s Name: 

Lender’s Address: 

 

 

 

5

-  .

 

EXHIBIT A

NOTICE OF CONVERSION

(To be executed by the Lender in order to convert the Note)

		
	
TO:  Emmaus Life Sciences, Inc.
	
 

 

	
The undersigned hereby irrevocably elects to convert $
	
 of the principal amount of the Note issued to the Lender by Emmaus Life Sciences, Inc. (the “Company”) into shares of Common Stock of the Company according to the conditions stated therein, as of the Conversion Date written below.

		
	
Conversion Date:
	
 

	
Applicable Conversion Price:
	
 

	
Signature:
	
 

	
Name:
	
 

	
Address:
	
 

	
Amount to be converted:
	
$  

	
Amount of Note unconverted:
	
$  

	
Number of shares of Common Stock to be issued:
	
 

	
Please issue the shares of  Common Stock in the following name and to the following address:
	
 

	
Address:
	
 

	
Address:
	
 

	
Phone Number:
	
 

 

 

 

 

 

 

 

6

-  .

 

EXHIBIT B

 

Optional Redemption of Conversion Shares:  On and after the “Redemption Date” (as hereinafter defined), the Borrower shall have the option, upon the Lender’s request and not less than ten (10) days' written notice to the Holder, to redeem and repurchase, from funds legally available therefor at the time of such redemption, any or all of the shares of Common Stock issued upon conversion of the Convertible Promissory Note to which this Exhibit is attached (the "Note") at a cash price per share of $9.00, subject to appropriate adjustment in the event of any stock split, stock dividend, recapitalization or similar change with respect to the Common Stock (as so adjusted, the “Redemption Price”), unless prior to the Redemption Date the Common Stock shall have been listed for trading on the NYSE AMEX, the New York Stock Exchange, the NASDAQ Stock Market or other national securities exchange in the United States or elsewhere, or become eligible for quotation in the United States on the OTCQB or OTCQX.  The “Redemption Date” means with respect to any particular shares of Common Stock the date two years after the date of issuance of the original Convertible Note.

 The Borrower's  redemption right set forth above shall terminate in the event the Borrower at any time shall consolidate with, merge into, or sell or convey all or substantially all its assets to, any other entity.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7

-  .

 

[INFORMATION FOR PURPOSES OF FILING WITH THE SECURITIES AND EXCHANGE COMMISSION]

 

SCHEDULE A

 

NOTEHOLDERS

 

	
Lender
	
 
	
Annual
Interest

Rate
	
 
	
Date of
loan
	
 
	
Term of
Loan
	
 
	
Loan Due
Date
	
 
	
Principal 

Loan
Amount
	
 
	
Interest 

Payment
Period
	
 
	
Conversion
Price
	
 
	
	
Sin Kon Martin Tam
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
9 months
	
 
	
8/15/2019
	
 
	
$
	
363,090 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Tak Shing Cheung
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
 

9 months
	
 
	
8/15/2019
	
 
	
$
	
182,088 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Winnie Suihim Chan 
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
9 months
	
 
	
8/15/2019
	
 
	
$
	
122,399 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Lam Chu Yan
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
 

 

9 months
	
 
	
8/15/2019
	
 
	
$
	
122,067 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Stanley Pei Luk
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
9 months
	
 
	
8/15/2019
	
 
	
$
	
66,677 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Shiu Hin Yee
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
 

9 months
	
 
	
8/15/2019
	
 
	
$
	
65,877 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Lai Sui Ping
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
9 months
	
 
	
8/15/2019
	
 
	
$
	
61,012 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Alison Brown-Carvalho
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
 

1 year
	
 
	
11/15/2019
	
 
	
$
	
36,680 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Woodchi Choy
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
9 months
	
 
	
8/15/2019
	
 
	
$
	
30,263 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Anand Ambrose & Dilrukshie Cooray Cornelio 
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
 

1 year
	
 
	
11/15/2019
	
 
	
$
	
12,269 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Reshan Cooray 
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
1 year
	
 
	
11/15/2019
	
 
	
$
	
12,269 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Roy & Valerie Cooray
	
 
	
10.0%
	
 
	
11/15/2018
	
 
	
 

1 year
	
 
	
11/15/2019
	
 
	
$
	
12,269 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Fun Hing Chan
	
 
	
10.0%
	
 
	
11/16/2018
	
 
	
9 months
	
 
	
8/16/2019
	
 
	
$
	
31,157 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Alexander Chi Hung Hioe
	
 
	
10.0%
	
 
	
11/21/2018
	
 
	
 

9 months
	
 
	
8/21/2019
	
 
	
$
	
77,682 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Kam Sang Marianne Young
	
 
	
10.0%
	
 
	
11/25/2018
	
 
	
9 months
	
 
	
8/25/2019
	
 
	
$
	
36,300 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Tseung Ming Joey Cheung
	
 
	
10.0%
	
 
	
11/25/2018
	
 
	
 

9 months
	
 
	
8/25/2019
	
 
	
$
	
16,335 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
Kar Man Cheung
	
 
	
10.0%
	
 
	
11/29/2019
	
 
	
9 months
	
 
	
8/29/2019
	
 
	
$
	
10,890 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

	
William Wai-Lit Lee & Susan Lee
	
 
	
10.0%
	
 
	
12/2/2018
	
 
	
9 months
	
 
	
9/2/2019
	
 
	
$
	
24,200 
	
 
	
Paid upon loan due date 
	
 
	
$
	
4.50
	
 

 

8

-  .

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}]]